Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Enteritis
MeSH D004751 - enteritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007410:
Intestinal diseases
0 Companies
0 Drugs
Success rate
D005759:
Gastroenteritis
55 Companies
7 Drugs
$
Success rate
D004751:
Enteritis
18 Companies
4 Drugs
$
Success rate
D004382:
Duodenitis
1 Company
1 Drug
$
Success rate
D007079:
Ileitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Takeda
Vedolizumab
Entyvio
2014-05-20
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100
%
2/2
Phase 2
0
%
0/2
Phase 3
75
%
3/4
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Ceftriaxone
,
Lidocaine
Takeda
Vedolizumab
Shire
Ontamalimab
Baxter
Ceftriaxone
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use